The nurse is teaching illness management to a group of clients and families in a community rehabilitation center. Which statement would be appropriate when warning clients and families considering the use of quack treatments?
A) Practitioners often claim to be persecuted by the scientific establishment.
B) Most practitioners rarely believe in what they are doing.
C) Advertising is frequently accurate in its description of the practice.
D) Treatment may involve legitimate therapies or techniques.
Ans: A
Feedback:
Quackery entails the use of methods not scientifically accepted and involves the practice of fraudulent medicine, usually to make money or for ego gratification and power. Practitioners may claim to be victims of the scientific establishment. Sometimes promoters of quackery engage in fraud and deliberate deception. In many cases, however, they sincerely believe in what they are doing and may be unwitting victims who share misinformation and personal anecdotes with others. Quackery and misleading advertising are frequent companions, such as labeling something as either therapeutic or harmful without scientific evidence.
You might also like to view...
The nurse is caring for a 24-year-old client newly diagnosed with schizophrenia. The client asks, "How could this be happening
What is wrong with my brain?" The nurse is most correct to identify which neurotransmitter as having the highest imbalance? A) Acetylcholine B) Dopamine C) Serotonin D) Gamma-aminobutyric acid
The diagnostic test result that the nurse would expect for a patient with polymyositis is:
1. a muscle biopsy positive for muscle degeneration. 2. a positive ANA (antinuclear antibody). 3. a 24-hour urine positive for urate crystals. 4. urate crystals in synovial fluid.
In comparison with lithium, carbamazepine, and divalproex, atypical antipsychotics:
a. may have some safety advantages b. are not appropriate for use in the treatment of bipolar disorder c. seem to be less effective in the treatment of bipolar disorder d. do not appear to work when used by themselves ("monotherapy")
Centrally acting anticholinergics used in the treatment of Parkinson's disease control symptoms by:
1. blocking cholinergic receptors. 2. activating dopamine receptors. 3. preventing the destruction of dopamine in the central nervous system. 4. increasing the synthesis of dopamine.